Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Phys Med Rehabil. 2003 Mar;84(3):329-34.

Continuous low-level heatwrap therapy for treating acute nonspecific low back pain.

Author information

1
Department of Physical Medicine and Rehabilitation, University of Medicine and Dentistry of New Jersey--New Jersey Medical School, Newark, NJ 07103, USA. sfnadler@cs.com

Abstract

OBJECTIVE:

To evaluate the efficacy of 8 hours of continuous low-level heatwrap therapy for the treatment of acute nonspecific low back pain (LBP).

DESIGN:

Prospective, randomized, parallel, single-blind (investigator), placebo-controlled, multicenter clinical trial.

SETTING:

Five community-based research facilities.

PARTICIPANTS:

Two-hundred nineteen subjects, aged 18 to 55 years, with acute nonspecific LBP.

INTERVENTION:

Subjects were stratified by baseline pain intensity and gender and randomized to one of the following groups: evaluation of efficacy (heatwrap, n=95; oral placebo, n=96) and blinding (oral ibuprofen, n=12; unheated back, wrap n=16). All treatments were administered for 3 consecutive days with 2 days of follow-up.

MAIN OUTCOME MEASURES:

Primary: day 1 mean pain relief (0- to 5-point verbal response scale). Secondary: muscle stiffness (101-point numeric rating scale), lateral trunk flexibility (fingertip-floor distance), and Roland-Morris Disability Questionnaire over 3 days of treatment and 2 days of follow-up.

RESULTS:

Heatwrap therapy was shown to provide significant therapeutic benefits when compared with placebo during both the treatment and follow-up period. On day 1, the heatwrap group had greater pain relief (1.76+/-.10 vs 1.05+/-.11, P <.001), less muscle stiffness (43.1+/-1.21 vs 47.6+/-1.21, P=.008), and increased flexibility (18.6+/-.44 cm vs 16.5+/-.45 cm, P=.001) compared with placebo. Disability was also reduced in the heatwrap group (5.3 vs 7.4, P=.0002). Adverse events were mild and infrequent.

CONCLUSION:

Continuous low-level heatwrap therapy was shown to be effective for the treatment of acute, nonspecific LBP.

PMID:
12638099
DOI:
10.1053/apmr.2003.50102
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center